检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:MA Junjie HU Gang XIE Lijun CHEN Lei XU Boxuan GONG Ping
机构地区:[1]Key Laboratory of Structure-based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China [2]Fujian Institute of Microbiology, Fuzhou 350007, P. R. China
出 处:《Chemical Research in Chinese Universities》2015年第6期958-963,共6页高等学校化学研究(英文版)
基 金:Supported by the Program for Liaoning Excellent Talents in University, China(No.LR2014030) and the National Natural Science Foundation of China(No.81102470).
摘 要:A series of novel benzothiazole derivatives bearing semicarbazone as a linker was designed and synthe- sized, and their in vitro antitumor activities were evaluated against four cancer cell lines(HT29, H460, A549 and MDA-MB-231). Most of them showed moderate to excellent activity against all the tested cell lines. Among them, compounds 12a--12i with fluoro-substituted benzyl-1H-indole moiety displayed more potent activity than those with phenyl moiety. The most promising compound 12d exhibited excellent antitumor activity with IC50 values of 0.015, 0.28, 1.53 and 0.68 p.mol/L against the four tested cell lines respectively.A series of novel benzothiazole derivatives bearing semicarbazone as a linker was designed and synthe- sized, and their in vitro antitumor activities were evaluated against four cancer cell lines(HT29, H460, A549 and MDA-MB-231). Most of them showed moderate to excellent activity against all the tested cell lines. Among them, compounds 12a--12i with fluoro-substituted benzyl-1H-indole moiety displayed more potent activity than those with phenyl moiety. The most promising compound 12d exhibited excellent antitumor activity with IC50 values of 0.015, 0.28, 1.53 and 0.68 p.mol/L against the four tested cell lines respectively.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7